Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT03616483

The Indiana Myeloma Registry

Conditions: Plasma Cell Dyscrasias

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 2500
Sponsor: Indiana University

Location: Indiana University Simon Cancer Center Indianapolis Indiana

Summary

This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research

Eligibility Criteria

Inclusion Criteria: 1. Male or female patients ≥ 18 years of age at the time of informed consent 2. Has been diagnosed with or is suspected to have one of the following: 1. Monoclonal Gammopathy of Undetermined Significance (MGUS) 2. Smoldering Multiple Myeloma 3. Multiple Myeloma 4. Bony or Soft Tissue Plasmacytoma 5. Primary Amyloidosis Exclusion Criteria: \< 18 years of age Have not been diagnosed with one of the following: Monoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT03616483). StuddyBuddy aggregates publicly available trial information.